Inga Jessen
YOU?
Author Swipe
View article: PTHP-18. Comparison of therapeutic approaches and multimodal molecular profiling in diffuse leptomeningeal glioneural tumor (DLGNT): Results from a European multicenter cohort
PTHP-18. Comparison of therapeutic approaches and multimodal molecular profiling in diffuse leptomeningeal glioneural tumor (DLGNT): Results from a European multicenter cohort Open
Diffuse leptomeningeal glioneural tumor (DLGNT) is a rare primary CNS tumor with a median age at diagnosis of 5 years. In 2016, the WHO Classification of Tumors of the Central Nervous System first recognized DLGNT as a distinct entity. The…
View article: PTHP-18. Comparison of therapeutic approaches and multimodal molecular profiling in diffuse leptomeningeal glioneural tumor (DLGNT): Results from a European multicenter cohort
PTHP-18. Comparison of therapeutic approaches and multimodal molecular profiling in diffuse leptomeningeal glioneural tumor (DLGNT): Results from a European multicenter cohort Open
Diffuse leptomeningeal glioneural tumor (DLGNT) is a rare primary CNS tumor with a median age at diagnosis of 5 years. In 2016, the WHO Classification of Tumors of the Central Nervous System first recognized DLGNT as a distinct entity. The…
View article: Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profiles
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profiles Open
Background Meningiomas represent the most common primary intracranial tumors in adults, with World Health Organization (WHO) grade 1 typically associated with favorable outcomes following gross total resection (GTR). Methods This retrospec…
View article: Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution
Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution Open
(1) Background: Recent publications foster stereotactic body radiotherapy (SBRT) in patients with adrenal oligometastases or oligoprogression. However, local control (LC) after non-adaptive SBRT shows the potential for improvement. Online …